Mucormycosis Clinical Core for the MUCOR-ADVANCE P01 Project

Not yet recruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2032

Conditions
Mucormycosis
Interventions
BEHAVIORAL

Mucormycosis

Tell the study team about any symptoms or side effects you have, follow study directions, and come to all study appointments (or contact the study team to reschedule).

Trial Locations (1)

77030

MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT06878144 - Mucormycosis Clinical Core for the MUCOR-ADVANCE P01 Project | Biotech Hunter | Biotech Hunter